CD19 and adrenal cortex carcinoma: In our immunohistochemistry analysis, samples from patients with ACC were analyzed for the expression of CD3, CD4, CD8, and CD19, and the results suggested that the ACC microenvironment exhibits low immunogenicity, as represented by low T and B-cells.